Xeris Biopharma COO Kevin McCulloch sells $250,000 in common shares

• Xeris Biopharma President and Chief Operating Officer Kevin McCulloch sold 25,000 common shares at USD 10 on Sept. 28, 2026.
• Directly held stake fell to 1,614,208 shares following the sale.
• Transaction was executed under a Rule 10b5-1 trading plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001867096-26-000078), on September 29, 2026, and is solely responsible for the information contained therein.